Cargando…
Inhibitory Effects of Fosmidomycin Against Babesia microti in vitro
Babesia microti, the main pathogen causing human babesiosis, has been reported to exhibit resistance to the traditional treatment of azithromycin + atovaquone and clindamycin + quinine, suggesting the necessity of developing new drugs. The methylerythritol 4-phosphate (MEP) pathway, a unique pathway...
Autores principales: | Wang, Sen, Li, Muxiao, Luo, Xiaoying, Yu, Long, Nie, Zheng, Liu, Qin, An, Xiaomeng, Ao, Yangsiqi, Chen, Jiaxu, Tian, Yu, Zhao, Junlong, He, Lan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198706/ https://www.ncbi.nlm.nih.gov/pubmed/32411701 http://dx.doi.org/10.3389/fcell.2020.00247 |
Ejemplares similares
-
Surface Antigen 1 Is a Crucial Secreted Protein That Mediates Babesia microti Invasion Into Host Cells
por: Li, Muxiao, et al.
Publicado: (2020) -
Kinetic Characterization and Inhibitor Screening of Pyruvate Kinase I From Babesia microti
por: An, Xiaomeng, et al.
Publicado: (2021) -
Evaluation of Babesia gibsoni GPI-anchored Protein 47 (BgGPI47-WH) as a Potential Diagnostic Antigen by Enzyme-Linked Immunosorbent Assay
por: Zhan, Xueyan, et al.
Publicado: (2019) -
Identification and molecular characterization of a novel Babesia orientalis thrombospondin-related anonymous protein (BoTRAP1)
por: Yu, Long, et al.
Publicado: (2018) -
Erythrocyte Adhesion of Merozoite Surface Antigen 2c1 Expressed During Extracellular Stages of Babesia orientalis
por: Nie, Zheng, et al.
Publicado: (2021)